DENVER, CO, Jan. 25 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH.OB) MIT is pleased to announce that it has redesigned the company website to reflect its new image.
Company President and CEO, Mr. Menassa, has decided to start the year 2010 with a new, strong, and positive image of Medical International Technology Inc. The new website's purpose will be to inform all shareholders about new developments in the following fields:
- Management & Advisory Board - Products - Latest News - Operations
Mr. Menassa will be at his office in China from January 17th to the 27th working with his partners in promoting MIT needle-free injectors for animals and humans. He will also meet with the Government personnel responsible for the certifications of the MED-JET products (SFDA). MIT China has now received the production license to produce all the Agro-Jet products and is in the process of receiving the production license for its Med-Jet products. Our goal is to start clinical trials in March of 2010. Mr. Menassa is also scheduled to meet with a few suppliers during his travels and evaluate the possibility of reducing costs in manufacturing its products.
Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.
About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.
The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.
SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.